Professional Documents
Culture Documents
Article
Biotransformation of Resveratrol: New Prenylated
trans-Resveratrol Synthesized by Aspergillus
sp. SCSIOW2
Liyan Wang 1,2, *, Yanhua Wu 1,2 , Yongtao Chen 1,2 , Jiaxin Zou 1,2 and Xiaofan Li 1,2, *
1 Shenzhen Key Laboratory of Marine Bioresource and Eco-environmental Science, College of Life Sciences
and Oceanography, Shenzhen University, Shenzhen 518060, China; 13723776301@139.com (Y.W.);
cyto2011@126.com (Y.C.); 13691608828@163.com (J.Z.)
2 Shenzhen Key Laboratory of Microbial Genetic Engineering, College of Life Sciences and Oceanography,
Shenzhen University, Shenzhen 518060, China
* Correspondence: lwang@szu.edu.cn (L.W.); lixiaof@szu.edu.cn (X.L.);
Tel.: +86-755-2601-2653 (L.W.); Fax: +86-755-2653-4274 (L.W.)
Abstract: Arahypin-16 (1), a new prenylated resveratrol with a unique dihydrobenzofuran ring, has
been isolated as a microbial metabolite of resveratrol (2) from whole-cell fermentation of Aspergillus
sp. SCSIOW2. The stereochemistry of 1 was determined by ECD calculations. 1 showed about
half of the extracellular radical scavenging effect (IC50 = 161.4 M) compared with resveratrol
(IC50 = 80.5 M), while on biomembranes it exhibited the same range of protection effects against
free radicals generated from AAPH (IC50 = 78.6 M and 87.9 M).
Keywords: resveratrol; prenylation; Aspergillus sp. SCSIOW2; ECD; erythrocyte protection activity;
DPPH scavenging activity
1. Introduction
Resveratrol is well known for the potential effects on coronary heart disease observed among
wine drinkers [1]. Nowadays resveratrol, which possesses a wide range of biological activities,
such as antioxidant, anti-inflammatory, antiviral, antimicrobial, anticancer, cardiovascular protection,
chemo-protection, neuro-protection and immune-modulation activity is one of the best studied natural
products [2]. Previous data have provided interesting insights into the effects of this compound on
the lifespan of different organisms and it might become a potential anti-aging agent in degenerative
human diseases [3]. However, any further medicinal application of resveratrol is limited due to its
low bioavailability and solubility. Researchers have found the addition of isoprenoid substituents on
various polyphenol skeletons significantly increased the bioactivity compared to similar compounds
that are not prenylated [4]. For example, the introduction of an 8-prenyl group induces estrogenic
activity in naringenin. Additionally, 8-prenylnaringenin is rapidly absorbed after oral administration,
compared with the generally poor oral bioavailability of flavonoids [5]. Therefore, different strategies
have been developed for synthesis of such compounds. The most commonly used organic synthetic
strategies are either activated by strong base or by coupling reactions catalyzed by metal salts.
Both reactions are usually carried out under extreme conditions and additional steps protection
and deprotection are needed. The chemoselectivity, regiochemistry, and number of prenyls are all
also difficult to control [6]. Recently, chemo-enzymatic syntheses using enzymes or whole cells
were also used for the synthesis of prenylated aromatic components. This type reactions are usually
regioselective, stereoselective and occur under mild conditions, thus the introduction of prenyl groups
into target compounds by the use of microorganisms represents an attractive alternative to conventional
uV(x10,000)
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 min
Figure
Figure 1.
1. The
The conversion
conversion of
of trans-resveratrol
trans-resveratrol into
into 11 is
is catalyzed
catalyzed by
by Aspergillus
Aspergillus sp.
sp. SCSIOW2.
SCSIOW2. (A):
(A):
Structures
Structures of trans-resveratrol (2) and arahypin-16 (1); (B): HPLC-UV chromatogram at 309 nm of
of trans-resveratrol (2) and arahypin-16 (1); (B): HPLC-UV chromatogram at 309 nm of
EtOAc
EtOAc extracts
extracts of
of untreated
untreated (a)
(a) and
and resveratrol-treated (b) fermentation
resveratrol-treated (b) fermentation broth.
broth.
Figure
Figure 2. Key 11H-
2. Key H-11H
HCOSY
COSYand
andHMBC
HMBCcorrelations
correlations of
of 11 and
and 2.
2.
a
1. NMR
Table 1.
Table NMR spectroscopic
spectroscopic data
data for
for compound
compound 11 (DMSO-d
(DMSO-d66)) a..
the calculated ECD spectrum of the 16-(S) enantiomer was opposite to the experimental ECD data
(Figure
Molecules 3). Hence,
2016, 21, 883 the stereochemistry of 1 was determined to be 16-(R). 4 of 9
10
0
190 240 290 340 390 440
-2
-4
-6
-8
10
regiospecific prenylation activity with resveratrol, generating arahypin-16 (1), a new component with
an unique dihydrobenzofuran ring. This is the first report about the prenylation of resveratrol by
fungal
Moleculesbiotransformation,
2016, 21, 883 which provided us a prenylated resveratrol, arahypin-16 (1), for further
5 of 9
Molecules 2016, 21, 883 5 of 9
bioactivity comparison.
100
100 1 50 M
*** 1 50 M
*** 1 70 M
protection rate(%)
80
1 70 M
protection rate(%)
80 *** 1 100 M
*** 1 100 M
60 1 140 M
60 1 140 M
***
40 *** *** ***P < 0.001
40 *** ***P < 0.001
EC = 78.6
20
20 EC5050= 78.6
0
0
50 70 100 140 Conc. (M)
50 70 100 140 Conc. (M)
150
150 Res 70 M
Res 70 M
Res 100 M
protection rate(%)
Res 100 M
protection rate(%)
Figure 4. Erythrocyte membrane protection rate (%) of arahypin-16 (1) and resveratrol (Res) against
Figure
Figure 4.
4. Erythrocyte
Erythrocytemembrane
membraneprotection
protectionrate
rate(%)
(%)of
ofarahypin-16
arahypin-16(1)
(1)and
andresveratrol
resveratrol (Res)
(Res) against
against
hemolysis induced by AAPH.
hemolysis
hemolysisinduced
inducedby
byAAPH.
AAPH.
Radical scavenging activity(%) Radical scavenging activity(%)
Radical scavening activity(%)
80 80
Radical scavenging activity(%) Radical scavenging activity(%)
Radical scavening activity(%)
80 1 10 M 80
1 10 M ***
1 20 M ***
60 *** 1 20 M 60
60 *** 1 40 M 60
*** 1 40 M
*** 1 80 M
40 *** 1 80 M 40
40 *** 1 160 M
*** 1 160 M 40
*** *** 1 320 M
1 320 M
20 *** ***P < 0.001 20
20 ***P < 0.001 20
EC50 = 161.4
0 EC50 = 161.4
0
0 10 20 40 80 160 320 Conc. (M) 0 1.0 1.5 2.0 2.5 3.0
10 20 40 80 160 320 Conc. (M) 1.0 1.5 2.0 2.5 3.0
log(Conc.)
Radical scavening activity(%)
80 80 log(Conc.)
Radical scavening activity(%)
80 ** Res 20 M 80
** Res 20 M
Res 40 M
60 ** Res 40 M 60
60 ** Res 80 M 60
** Res 80 M
** Res 160 M
40 Res 160 M 40
40 ** **P < 0.01 40
** **P < 0.01
** EC50 = 80.5
20 ** EC50 = 80.5 20
20 20
0 0
0 10 0 0.5
20 40 80 160 Conc. (M) 1.0 1.5 2.0 2.5
10 20 40 80 160 Conc. (M) 0.5 1.0 1.5
log(Conc.)
2.0 2.5
log(Conc.)
Figure 5. DPPH radical scavenging activity (%) of arahypin-16 (1) and resveratrol (Res).
Figure 5. DPPH radical scavenging activity (%) of arahypin-16 (1) and resveratrol (Res).
Figure 5. DPPH radical scavenging activity (%) of arahypin-16 (1) and resveratrol (Res).
3.2. Strain
Fungus SCSIOW2 was isolated from a deep marine sediment sample collected in the South China
Sea (112 30.203E, 18 1.654N) at a depth of 2439 m. This fungus was characterized as Aspergillus sp.
Based on the analysis of the ITS region sequence with Genebank S1. This fungus was deposited in the
Marine Microbial Lab., College of Life Science, Shenzhen University (Shenzhen, China).
4. Conclusions
In summary, we have reported the conversion of trans-resveratrol to arahypin-16 (1) catalyzed by
Aspergillus sp. SCSIOW2. This is the first trans-resveratrol derivative containing a dihydrobenzofuran
ring and the first report concerning prenylation of resveratrol by direct fungal biotransformation.
Arahypin-16 (1) showed about half the extracellular radical scavenging of resveratrol, while it exhibited
the same range of protective effect on biomembranes against free radicals produced by AAPH. This is
also the first report on the biomembrane protection activities of resveratrol and its derivatives.
References
1. Frankel, E.N.; Waterhouse, A.L.; Kinsella, J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993,
341, 11031104. [CrossRef]
2. Liu, Y.; Liu, Y.; Chen, H.; Yao, X.; Xiao, Y.; Zeng, X.; Zheng, Q.; Wei, Y.; Song, C.; Zhang, Y.; et al. Synthetic
resveratrol derivatives and their biological activities: A review. Open J. Med. Chem. 2015, 5, 97105. [CrossRef]
3. Lanc, A.; Kaminski, J.; Tili, E. Control of microRNA expression as a new way for resveratrol to deliver its
beneficial effects. J. Agric. Food Chem. 2012, 60, 87838789. [CrossRef] [PubMed]
4. Siregar, T.M.; Cahyana, H.; Wibowo, W. Application of superbase catalyst -Al2 O3 /NaOH/Na for
prenylation reaction of resveratrol (3,5,41 -trihydroxystilbene). J. Chem. Pharm. Res. 2014, 6, 349353.
5. Rad, M.; Huemperl, M.; Schaefer, O.; Schoemaker, R.C.; Schleuniing, W.D.; Cohen, A.F. Pharmacokinetics
and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to
postmenopausal women. J. Br. J. Clin. Pharmacol. 2006, 62, 288296. [CrossRef] [PubMed]
6. Fan, A.; Winkelblech, J.; Li, S. Impacts and perspectives of prenyltransferases of the DMATS superfamily for
use in biotechnology. Appl. Microbiol. Biot. 2015, 99, 73997415. [CrossRef] [PubMed]
7. Okamoto, R.; Izumi, M.; Kajihara, Y. Decoration of proteins with sugar chains: recent advances in
glycoprotein synthesis. Curr. Opin. Chem. Biol. 2014, 22, 9299. [CrossRef] [PubMed]
8. Yu, X.; Liu, Y.; Xie, X.; Zheng, X.; Li, S. Biochemical characterization of indole prenyltransferases: Filling the
last gap of prenylation positions by a 5-dimethylallyltryptophan synthase from Aspergillus clavatus. J. Biol.
Chem. 2012, 287, 13711380. [CrossRef] [PubMed]
9. Sobolev, V.S.; Krausert, N.M.; Gloer, J.B. New Monomeric stilbenoids from peanut (Arachis hypogaea) seeds
challenged by an Aspergillus flavus strain. J. Agric. Food Chem. 2016, 64, 579584. [CrossRef] [PubMed]
10. Aisyah, S.; Gruppen, H.; Slager, M.; Helmink, B.; Vincken, J. Modification of prenylated stilbenoids in peanut
(Arachis hypogaea) seedlings by the same Fungi that elicited them: the Fungus strikes back. J. Agric. Food
Chem. 2015, 63, 92609268. [CrossRef] [PubMed]
11. Sobolev, V.S.; Neff, S.A.; Gloer, J.B. New dimeric stilbenoids from fungal-challenged peanut (Arachis hypogaea)
seeds. J. Agric. Food Chem. 2010, 58, 875881. [CrossRef] [PubMed]
12. Yan, S.L.; Su, Y.F.; Chen, L.; Que, M.; Gao, X.M.; Chang, J.B. Polygonumosides A-D, stilbene derivatives from
processed roots of Polygonum multiflorum. J. Nat. Prod. 2014, 77, 397401. [CrossRef] [PubMed]
Molecules 2016, 21, 883 9 of 9
13. Nugroho, E.A.; Morita, H. Circular dichroism calculation for natural products. J. Nat. Med. 2014, 68, 110.
[CrossRef] [PubMed]
14. XedeX. Available online: http://www.cresset-group.com (accessed on 5 July 2015).
15. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.;
Mennucci, B.; Petersson, G.A.; et al. Gaussian 09, Revision D. 01; Gaussian Inc.: Wallingford, CT, USA, 2013.
16. Bruhn, T.; Schaumlffel, A.; Hemberger, Y.; Bringmann, G. SpecDis, Version 1.60; University of Wuerzburg:
Wuerzburg, Germany, 2013.
17. Bruhn, T.; Schaumlffel, A.; Hemberger, Y.; Bringmann, G. SpecDis: Quantifying the comparison of calculated
and experimental electronic circular dichroism spectra. Chirality 2013, 25, 243249. [CrossRef] [PubMed]
18. Chaudhuri, S.; Banerjee, A.; Basu, K.; Sengupta, B.; Sengupta, P.K. Interaction of flavonoids with red blood
cell membrane lipids and proteins: antioxidant and antihemolytic effects. Int. J. Boil. Macromol. 2007, 41,
4248. [CrossRef] [PubMed]
19. Banerjee, A.; Kunwar, A.; Mishra, B.; Priyadarsini, K.I. Concentration dependent antioxidant/pro-oxidant
activity of curcumin studies from AAPH induced hemolysis of RBCs. Chemico-Biol. Interact. 2008, 174,
134139. [CrossRef] [PubMed]
20. Bruno, B.; Giuliano, D.M.; Pilar, M.; Alberto, B. Novel prenyltransferase enzymes as a tool for flavonoid
prenylation. TRENDS Pharmacol. Sci. 2005, 26, 606608.
21. Niki, E.; Komuro, E.; Takahashi, M.; Urano, S.; Ito, E.; Terao, K. Oxidative hemolysis of erythrocytes and its
inhibition by free radical scavengers. J. Boil. Chem. 1988, 263, 1980919814.
22. Li, X.; Li, L.; Wang, J.; Wang, T.; Wang, L. Two new lignans with antioxidative activities from Jatropha curcas.
Nat. Prod. Res. 2014, 28, 19851991. [CrossRef] [PubMed]
Samples Availability: Samples of the compounds 1 and 2 are available from the authors.
2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Copyright of Molecules is the property of MDPI Publishing and its content may not be copied
or emailed to multiple sites or posted to a listserv without the copyright holder's express
written permission. However, users may print, download, or email articles for individual use.